Antimicrobial Treatment Duration in Sepsis and Serious Infections

Area of Science:

• Infectious Diseases
• Pharmacology
• Critical Care Medicine

Background:

• Sepsis management has improved with early recognition and antimicrobial administration.
• Limited guidance exists for optimal antimicrobial duration in sepsis.
• Reduced antibiotic exposure offers benefits like lower resistance and healthcare costs.

Purpose of the Study:

• To review existing evidence on antimicrobial duration in sepsis.
• To identify data gaps and challenges in shortening antimicrobial therapy for sepsis.
• To inform strategies for safe and effective antimicrobial use in sepsis.

Main Methods:

• Narrative review of current scientific literature.
• Analysis of evidence regarding antimicrobial treatment duration in sepsis.
• Identification of limitations in existing trial designs and patient populations.

Main Results:

• Evidence on optimal antimicrobial duration in sepsis is notably limited.
• Many trials exclude critically ill patients or use noninferiority designs.
• Challenges include source control, multidrug-resistant organisms, and altered pharmacokinetics.

Conclusions:

• Further studies are essential to guide safe reduction of antimicrobial exposure in sepsis.
• Targeted research is needed for high-risk sepsis patients to balance safety and effectiveness.
• Optimizing antimicrobial duration can mitigate adverse outcomes and healthcare expenses.